The current valuation score of Lisata Therapeutics Inc is 6.10, ranking 357 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.81, which is -88.03% below the recent high of -0.22 and -47.00% above the recent low of -2.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.